The advanced stages of CTCL, with typical severe pruritus, shift toward a predominant Th2-cell microenvironment releasing cytokines such as IL-4, IL-5, or IL-31 that have gained attention in other itching inflammatory disorders [2, 61, 62]. The gene discussed is IL5; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.